BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31450767)

  • 1. Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma.
    Papoutsoglou P; Louis C; Coulouarn C
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance].
    Zhang BY; Zhang JY; Zhao K; Wu LQ
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):846-9. PubMed ID: 16083599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma.
    Papoutsoglou P; Pineau R; Leroux R; Louis C; L'Haridon A; Foretek D; Morillon A; Banales JM; Gilot D; Aubry M; Coulouarn C
    EMBO Rep; 2024 Mar; 25(3):1022-1054. PubMed ID: 38332153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of transforming growth factor-beta signaling in pancreatic cancer.
    Lin X; Feng XH
    World J Surg; 2005 Mar; 29(3):312-6. PubMed ID: 15706432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway.
    Qiao P; Li G; Bi W; Yang L; Yao L; Wu D
    BMC Cancer; 2015 Jun; 15():469. PubMed ID: 26077733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma.
    Sugimachi K; Nishio M; Aishima S; Kuroda Y; Iguchi T; Komatsu H; Hirata H; Sakimura S; Eguchi H; Bekki Y; Takenaka K; Maehara Y; Suzuki A; Mimori K
    Oncology; 2017; 93(1):67-74. PubMed ID: 28448997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.
    Oliveira DV; Zhang S; Chen X; Calvisi DF; Andersen JB
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):349-356. PubMed ID: 28162004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic roles of TGFβ/Smad signaling in the progression of chronic liver disease.
    Xu L; Tian D; Zheng Y
    Crit Rev Eukaryot Gene Expr; 2013; 23(3):237-55. PubMed ID: 23879540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.
    Sulpice L; Rayar M; Desille M; Turlin B; Fautrel A; Boucher E; Llamas-Gutierrez F; Meunier B; Boudjema K; Clément B; Coulouarn C
    Hepatology; 2013 Dec; 58(6):1992-2000. PubMed ID: 23775819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade.
    Mullenders J; Fabius AW; van Dongen MM; Kuiken HJ; Beijersbergen RL; Bernards R
    Mol Cancer Res; 2010 Apr; 8(4):592-603. PubMed ID: 20332216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β signaling in liver and gastrointestinal cancers.
    Katz LH; Likhter M; Jogunoori W; Belkin M; Ohshiro K; Mishra L
    Cancer Lett; 2016 Sep; 379(2):166-72. PubMed ID: 27039259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.
    Guo J; Canaff L; Rajadurai CV; Fils-Aimé N; Tian J; Dai M; Korah J; Villatoro M; Park M; Ali S; Lebrun JJ
    Breast Cancer Res; 2014 Dec; 16(6):476. PubMed ID: 25499443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.
    Lee KT; Liu TS
    World J Surg; 2003 Oct; 27(10):1143-8. PubMed ID: 12917766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
    AlHossiny M; Luo L; Frazier WR; Steiner N; Gusev Y; Kallakury B; Glasgow E; Creswell K; Madhavan S; Kumar R; Upadhyay G
    Cancer Res; 2016 Jun; 76(11):3376-86. PubMed ID: 27197181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting TGFbeta signaling for cancer therapy.
    Iyer S; Wang ZG; Akhtari M; Zhao W; Seth P
    Cancer Biol Ther; 2005 Mar; 4(3):261-6. PubMed ID: 15846079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma.
    Merdrignac A; Angenard G; Allain C; Petitjean K; Bergeat D; Bellaud P; Fautrel A; Turlin B; Clément B; Dooley S; Sulpice L; Boudjema K; Coulouarn C
    Hepatol Commun; 2018 Mar; 2(3):254-269. PubMed ID: 29507901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.